AKERO THERAPEUTICS INC's ticker is and the CUSIP is 00973Y958. A total of 5 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,980,040 | -58.4% | 138,000 | -61.6% | 0.00% | -66.7% |
| Q2 2023 | $16,785,055 | +478.0% | 359,500 | +373.6% | 0.01% | +500.0% |
| Q1 2023 | $2,903,934 | -74.2% | 75,900 | -63.0% | 0.00% | -80.0% |
| Q4 2022 | $11,250,440 | +206.0% | 205,300 | +90.1% | 0.01% | +150.0% |
| Q3 2022 | $3,677,000 | – | 108,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 75,900 | $2,903,934 | 0.00% |
| SIMPLEX TRADING, LLC | 15,200 | $581 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,700 | $65,042 | 0.00% |
| JPMORGAN CHASE & CO | 11,100 | $425,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |